Results

1–10 of 151 results for Inflammatory and Infectious Diseases

Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase 2 Study (NEPTUNE)
Robert C. Wang, MD, FASRS
Annual Meeting Talks
2024
IL-6 Inhibition With Vamikibart in Patients With Uveitic Macular Edema: Phase 3 MEERKAT and SANDCAT Trials
Anat Loewenstein, MD
Annual Meeting Talks
2024
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Danny A. Mammo, MD
Annual Meeting Talks
2024
High-Order Imaging Outcomes Using SD-OCT and Ultra-Widefield Fluorescein Angiography in Pediatric Uveitis Patients Treated With Adalimumab
Sunil Srivastava, MD
Annual Meeting Talks
2024
New Treatment Paradigm for Infectious Endophthalmitis: Results From the Mexican Endophthalmitis Study Group Protocol 1 and 3
Raul Velez-Montoya, MD
Annual Meeting Talks
2024
Intraocular tPA During Vitrectomy for the Management of Severe Bacterial Endophthalmitis
Emmanuel Chang, MD PhD FACS FASRS
Updates from the Field
2025
Fungal Endophthalmitis
Gaurav K. Shah, MD
Retina Image Bank: Images of the Week
2025
Endophthalmitis After Intravitreal Injections with 0.05% Aqueous Chlorhexidine vs 5% Povidone-Iodine as Ocular Antiseptics
Murtaza K Adam, MD
Annual Meeting Talks
2022
Biomarkers in the Vitreous Humor Correlate With Alzheimer’s Disease and Chronic Traumatic Encephalopathy in Postmortem Eyes and Brain
Manju L. Subramanian, MD
Annual Meeting Talks
2022
Association of OCT Choroidal Thickness Maps and Automated Fixed-Depth Intensity Maps With Disease Activity in Birdshot Chorioretinopathy
Keirnan Willett, MD
Annual Meeting Talks
2022